KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $43,000 | -8.5% | 11,500 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $47,000 | -11.3% | 11,500 | 0.0% | 0.01% | -28.6% |
| Q4 2017 | $53,000 | -35.4% | 11,500 | 0.0% | 0.01% | -36.4% |
| Q3 2017 | $82,000 | -1.2% | 11,500 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $83,000 | +3.8% | 11,500 | -11.5% | 0.01% | +10.0% |
| Q1 2017 | $80,000 | +19.4% | 13,000 | +13.0% | 0.01% | +25.0% |
| Q4 2016 | $67,000 | +26.4% | 11,500 | +15.0% | 0.01% | +14.3% |
| Q3 2016 | $53,000 | -19.7% | 10,000 | 0.0% | 0.01% | -12.5% |
| Q2 2016 | $66,000 | +40.4% | 10,000 | 0.0% | 0.01% | +33.3% |
| Q1 2016 | $47,000 | -7.8% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $51,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |